|
UTP15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.968300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.617600E-02 |
| Normal-vs-Stage2 |
2.670400E-01 |
| Normal-vs-Stage3 |
9.225000E-01 |
| Normal-vs-Stage4 |
3.178200E-01 |
| Stage1-vs-Stage2 |
9.722400E-01 |
| Stage1-vs-Stage3 |
2.450000E-01 |
| Stage1-vs-Stage4 |
8.173400E-01 |
| Stage2-vs-Stage3 |
4.376600E-01 |
| Stage2-vs-Stage4 |
8.454400E-01 |
| Stage3-vs-Stage4 |
6.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.650200E-02 |
| Normal-vs-AfricanAmerican |
7.603900E-02 |
| Normal-vs-Asian |
6.820200E-01 |
| Caucasian-vs-AfricanAmerican |
7.514600E-01 |
| Caucasian-vs-Asian |
3.197000E-01 |
| AfricanAmerican-vs-Asian |
2.329000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.409780E-02 |
| Normal-vs-Female |
8.405400E-01 |
| Male-vs-Female |
1.660460E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.112500E-02 |
| Normal-vs-Extreme_Weight |
1.335960E-02 |
| Normal-vs-Obese |
4.235400E-01 |
| Normal-vs-Extreme_Obese |
7.156300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.876400E-01 |
| Normal_Weight-vs-Obese |
2.883000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.147600E-01 |
| Extreme_Weight-vs-Obese |
1.549760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.399600E-01 |
| Obese-vs-Extreme_Obese |
1.989810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.811400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.598200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.411900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.838670E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.263400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.662600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.102100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.708560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.459600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.343600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.085630E-02 |
| Normal-VS-Type2 PRCC |
4.732600E-01 |
| Normal-VS-KIRP CIMP |
3.058400E-01 |
| Normal-VS-Unclassified PRCC |
6.495000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.242400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.000800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.155600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.233400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.990200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.607400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.105000E-03 |
| Normal-vs-N1 |
5.138400E-01 |
| Normal-vs-N2 |
6.434000E-01 |
| N0-vs-N1 |
1.639730E-02 |
| N0-vs-N2 |
5.252400E-01 |
| N1-vs-N2 |
6.266600E-01 |
|
|
